TORONTO - Health Canada has approved the first drug designed to treat postpartum depression.
Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.
The Canadian Press1 hrs ago
TORONTO - Health Canada has approved the first drug designed to treat postpartum depression.
Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.